|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/127 | (2006.01) | ||
| A61K 38/00 | (2006.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 47/14 | (2017.01) | ||
| A61K 47/24 | (2006.01) | ||
| A61P 1/00 | (2006.01) | ||
| A61P 1/12 | (2006.01) | ||
| A61P 1/18 | (2006.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 5/00 | (2006.01) | ||
| A61P 5/02 | (2006.01) | ||
| A61P 5/14 | (2006.01) | ||
| A61P 5/46 | (2006.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 2714004 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12731315.3 |
| Date of filing the European patent application | 2012-05-25 | |
| (97) | Date of publication of the European application | 2014-04-09 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-15 |
| (46) | Date of publication of the claims translation | 2024-08-12 |
| (86) | Number | PCT/EP2012/059917 |
| Date | 2012-05-25 |
| (87) | Number | WO 2012/160213 |
| Date | 2012-11-29 |
| (30) | Number | Date | Country code |
| 201161489886 P | 2011-05-25 | US |
| (72) |
TIBERG, Fredrik , SE
NISTOR, Catalin , SE
JOHNSSON, Markus , SE
|
| (73) |
Camurus AB ,
Ideon Science Park, 223 70 Lund,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kontroliuojamo atpalaidavimo peptidų vaistinės formos |
| CONTROLLED RELEASE PEPTIDE FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2025-05-05 | 14 | 289.00 EUR |
| 2026-05-25 |